Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses
ABSTRACT The live attenuated yellow fever virus (YFV) vaccine 17D stands as a “gold standard” for a successful vaccine. 17D was developed empirically by passaging the wild-type Asibi strain in mouse and chicken embryo tissues. Despite its immense success, the molecular determinants for virulence att...
Guardado en:
Autores principales: | Maria Dolores Fernandez-Garcia, Laurent Meertens, Maxime Chazal, Mohamed Lamine Hafirassou, Ophélie Dejarnac, Alessia Zamborlini, Philippe Despres, Nathalie Sauvonnet, Fernando Arenzana-Seisdedos, Nolwenn Jouvenet, Ali Amara |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01c8d676a9da462694b2b0beecc6ea31 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine
por: Florian Bakoa, et al.
Publicado: (2021) -
A Sensitive Yellow Fever Virus Entry Reporter Identifies Valosin-Containing Protein (VCP/p97) as an Essential Host Factor for Flavivirus Uncoating
por: Harish N. Ramanathan, et al.
Publicado: (2020) -
Risk of yellow fever virus transmission in the Asia-Pacific region
por: Lucy de Guilhem de Lataillade, et al.
Publicado: (2020) -
Diffusion of sylvatic yellow fever in the state of São Paulo, Brazil
por: Alec Brian Lacerda, et al.
Publicado: (2021) -
An updated antennal lobe atlas for the yellow fever mosquito Aedes aegypti.
por: Shruti Shankar, et al.
Publicado: (2020)